Divi's Lab Q4 net up 78% at Rs 895 cr, revenue rises 41% to Rs 2,518 cr

Divi's Laboratories on Monday said its consolidated net profit increased by 78 per cent to Rs 895 crore in the quarter ended on March 31, 2022.

Divi's Laboratories
Press Trust of India New Delhi
1 min read Last Updated : May 23 2022 | 3:28 PM IST

Divi's Laboratories on Monday said its consolidated net profit increased by 78 per cent to Rs 895 crore in the quarter ended on March 31, 2022.

The drug maker had reported a net profit of Rs 502 crore in the January-March quarter of 2020-21 fiscal.

Revenue from operations rose to Rs 2,518 crore for the fourth quarter ended on March 31, 2022, as against Rs 1,788 crore in the year-ago period, Divi's Laboratories said in a regulatory filing.

For the year ended in March 2022, the company posted a consolidated net profit of Rs 2,960 crore as against Rs 1,984 crore in FY21.

Revenue from operations rose to Rs 8,960 crore as compared with Rs 6,969 crore in 2020-21.

The company said its board has recommended a dividend of Rs 30 per share of face value Rs 2 (1,500 per cent) for 2021-22, subject to approval of members at the ensuing annual general meeting.

Shares of the company were trading 6.37 per cent down at Rs 4,032.35 apiece on the BSE.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Divi's labQ4 Results

First Published: May 23 2022 | 3:28 PM IST

Next Story